Timeline
RA Capital Management
Boston crossover biotech fund; co-invested in CellCentric's £170m Series D.
1 of 1 entries (1 events, 0 interactions)
Filters
#45 May
Boston crossover biotech fund; co-invested in CellCentric's £170m Series D.
1 of 1 entries (1 events, 0 interactions)